Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States and in Israel. It is testing MG01CI 1400 mg Compared With Placebo for ADHD.
Multiple locations, including Gainesville
This study is completed in China. It is testing sulforaphane Effects for schizophrenia.
In ChangshaThis study is ongoing in the United Kingdom. It is testing efficacy of Lurasidone Adjunctive Therapy for Bipolarity.
In United KingdomThis study is completed in South Korea. It is testing Lurasidone HCL for schizophrenia.
In SeoulThis study was withdrawn in Global. It is testing Safety and Efficacy of Methylphenidate HCl ERCT for ADHD.
In GlobalThis study was withdrawn in Global. It is testing Safety and Efficacy of Quillichew ERCT for ADHD.
In GlobalThis study is completed. It focuses on depression and currently lists study information in the United States.
In LawrenceThis study is active but not recruiting. It focuses on addiction and currently lists study information in the United States.
In HoustonThis study is completed. It focuses on ADHD and currently lists study information in Turkey.
In Bursa
This study is completed. It focuses on PTSD and currently lists study information in Sweden.
In StockholmThis study is completed. It focuses on PTSD and currently lists study information in Sweden.
In StockholmThis study is completed. It focuses on schizophrenia and currently lists study information in the United States.
Multiple locations, including BedfordHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.